Pristine Pharma

Semaglutide Tablets 14 mg are an innovative GLP-1 receptor agonist medication used primarily for the management of type 2 diabetes mellitus and for supporting weight management in adults with obesity or overweight conditions. Semaglutide helps regulate blood sugar levels by stimulating insulin secretion, suppressing glucagon release, and reducing appetite, thereby promoting effective glycemic control and weight reduction.

These tablets provide a convenient oral alternative to injectable GLP-1 therapies, offering patients ease of administration without compromising efficacy.

Key Features:

• Active Ingredient: Semaglutide 14 mg

• Dosage Form: Oral tablet

• Indications: Type 2 diabetes, weight management in adults

• Mechanism of Action: GLP-1 receptor agonist; enhances insulin secretion and reduces appetite

• Packaging: Blister packs for secure storage and dosage compliance

• Quality Assurance: Manufactured under GMP-certified facilities ensuring safety and effectiveness

Benefits:

• Helps control blood sugar levels effectively in type 2 diabetes

• Supports weight loss and appetite regulation

• Convenient oral administration, improving patient compliance

• Clinically proven to improve metabolic health and reduce cardiovascular risk

The 14 mg Rybelsus tablet is a high-dose oral medication containing semaglutide, used in adults with type 2 diabetes, along with diet and exercise, to improve blood sugar control. The 14 mg strength is typically reached after gradually increasing from lower doses to minimize gastrointestinal side effects.